Restart Life Sciences Corp. (NMLSF) Research

Restart Life Sciences Corp. functions as a biotechnology firm, with its primary focus being the exploration and advancement of psilocybin. The company's offerings encompass therapeutic treatments and diagnostic instruments specifically developed for neuroinflammatory conditions. Established on October 27, 2004, its principal operations are located in Vancouver, Canada.

Market snapshot

Symbol
NMLSF
Price
$0.07
Day change
0.00%
Market cap
$3.3M
P/E ratio
-2.19x
52-week range
0.0101-0.12422
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • America Great Health (AAGH)
  • Ayala Pharmaceuticals, Inc. (ADXS)
  • Algernon Pharmaceuticals Inc. (AGNPF)
  • Agentix Corp. (AGTX)
  • Appili Therapeutics Inc. (APLIF)
  • Health Sciences Group, Inc. (HESG)
  • Universal Ibogaine Inc. (IBOGF)
  • Regen BioPharma, Inc. (RGBP)

Open Restart Life Sciences Corp. (NMLSF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.